Filing Details

Accession Number:
0001399529-21-000146
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-10 20:06:31
Reporting Period:
2021-08-10
Accepted Time:
2021-08-10 20:06:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1399529 Dicerna Pharmaceuticals Inc DRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1259856 Douglas Fambrough C/O Dicerna Pharmaceuticals, Inc.
75 Hayden Avenue
Lexington MA 02421
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-10 5,000 $22.10 43,164 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $22.035 to $22.11, inclusive. The Reporting Person undertakes to provide to Dicerna Pharmaceuticals, Inc., any security holder of Dicerna Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).